OnCore Login

Return to Trial Database

LUN01-24

A Phase III Trial of Cisplatin/Etoposide/Radiotherapy With or Without Consolidation Docetaxel in Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN01-24

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

The impact of PET imaging on outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with chemoradiation
  • NH Jayaram, MA Neubauer, CS Johnson, T Breen, CE Williams, NH Hanna
Rates and Risk of Pneumonitis in Non-Small Cell Lung Carcinoma (NSCLC) Patients (pts) Treated with Concurrent Chemoradiation
  • RB Barriger, JC Aseneau, M Yu, C Reynolds, P Mantravadi, M Neubauer, AJ Fakiris, A White, N Hanna, RC McGarry
Phase III Trial of Cisplatin (P) plus Etoposide (E) plus Concurrent Chest Radiation (XRT) with or without Consolidation Docetaxel (D) in Patients (pts) with Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC)
  • L Mina, M Neubauer, R Ansari, R Govindan, L Einhorn, W Fisher, D Bruetman, N Chowhan, C Johnson, N Hanna
Predictors of toxicity to consolidation docetaxel (D) following cisplatin (P) plus etoposide (E) plus concurrent radiation (XRT) in patients (pts) with stage III non-small cell lung cancer (NSCLC) treated on a phase III randomized trial
  • V Cook, N Hanna, T Breen, A White, J Wu
Prognostic Factors For Survival In Patients With Unresectable Stage III Non-Small Cell Lung Cancer From a Phase III Randomized Trial
  • F Ademuyiwa, C Johnson, A White, T Breen, J Harvey, M Neubauer, N Hanna
An analysis of elderly patients (pts) treated on a phase III trial of cisplatin (P) plus etoposide (E) with concurrent radiotherapy (CRT) followed by docetaxel (D) vs observation (O) in pts with stage III non small cell lung cancer (NSCLC)
  • MM Sgroi, M Neubauer, R Ansari, R Govindan, D Bruetman, W Fisher, C Johnson, T Breen, C Yiannoutsos, N Hanna
Multivariate Analysis of Prognostic Variables Associated with Survival from a Phase III Study of Cisplatin (P) plus Etoposide (E) plus Chest Radiation (XRT) with or without Consolidation Docetaxel (D) in Patients with Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
  • FO Ademuyiwa, N Hanna, C Johnson, T Breen, C Yiannoutsos, A White
Phase III Study of Cisplatin (P) plus Etoposide (E) with Concurrent Chest Radiation (XRT) followed by Docetaxel (D) vs. Observation in Patients (pts) with Stage III Non-small Cell Lung Cancer (NSCLC): An Interim Toxicity Analysis of Consolidation Therapy
  • P Bedano, M Neubauer, R Ansari, R Govindan, L Einhorn, D Bruetman, A White, T Breen, B Juliar, N Hanna
Prognostic factors in stage III non-small cell lung cancer
  • F Ademuyiwa, C Johnson, A White, T Breen, J Harvey, M Neubauer, N Hanna
Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC)
  • N Hanna, M Neubauer, R Ansari, R Govindan, D Bruetman, W Fisher, N Chowhan, S Nattam, C Yiannoutsos, L Einhorn
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial
  • SI Jalal, HD Riggs, A Melnyk, D Richards, A Agarwala, M Neubauer, R Ansari, R Govindan, D Bruetman, W Fisher, T Breen, CS Johnson, M Yu, L Einhorn, N Hanna
Dose Volume Analysis of Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Concurrent Cisplatinum and Etoposide with or without Consolidation Docetaxel
  • B Barriger, A Fakiris, N Hanna, M Yu, P Mantravadi, R McGarry
Cisplatin plus Etoposide plus Concurrent Chest Radiation with or without Consolidation Docetaxel in Patients with Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase III Study
  • N Hanna, M Neubauer, C Yiannoutsos, R McGarry, J Arseneau, R Ansari, C Reynolds, R Govindan, A Melnyk, W Fisher, D Richards, D Bruetman, T Anderson, N Chowhan, S Nattam, P Mantravadi, C Johnson, T Breen, A White, L Einhorn

Trial Locations

All sites in which the trial LUN01-24 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278